Cargando…

T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease

Parkinson disease (PD) is a progressive neurological disease caused by selective degeneration of dopaminergic (DA) neurons in the substantia nigra. Although most cases of PD are sporadic cases, familial PD provides a versatile research model for basic mechanistic insights into the pathogenesis of PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabata, Yoshikuni, Imaizumi, Yoichi, Sugawara, Michiko, Andoh-Noda, Tomoko, Banno, Satoe, Chai, MuhChyi, Sone, Takefumi, Yamazaki, Kazuto, Ito, Masashi, Tsukahara, Kappei, Saya, Hideyuki, Hattori, Nobutaka, Kohyama, Jun, Okano, Hideyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234903/ https://www.ncbi.nlm.nih.gov/pubmed/30344006 http://dx.doi.org/10.1016/j.stemcr.2018.09.006

Ejemplares similares

Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors
por: Chai, MuhChyi, et al.
Publicado: (2018)

Non-Cell-Autonomous Neurotoxicity in Parkinson’s Disease Mediated by Astroglial α-Synuclein
por: Chai, MuhChyi, et al.
Publicado: (2019)

Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells
por: Sanosaka, Tsukasa, et al.
Publicado: (2022)

Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
por: Isoda, Miho, et al.
Publicado: (2023)

Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
por: Suda, Yukari, et al.
Publicado: (2018)

Controlling the Regional Identity of hPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes
por: Imaizumi, Kent, et al.
Publicado: (2015)

Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
por: Yokota, Mutsumi, et al.
Publicado: (2021)

Human PSCs determine the competency of cerebral organoid differentiation via FGF signaling and epigenetic mechanisms
por: Ideno, Hirosato, et al.
Publicado: (2022)

Aging-related motor function and dopaminergic neuronal loss in C57BL/6 mice
por: Noda, Sachiko, et al.
Publicado: (2020)

Hypoxia Epigenetically Confers Astrocytic Differentiation Potential on Human Pluripotent Cell-Derived Neural Precursor Cells
por: Yasui, Tetsuro, et al.
Publicado: (2017)

Modeling neurodevelopment in a dish with pluripotent stem cells
por: Imaizumi, Kent, et al.
Publicado: (2020)

Gene therapy using genome‐edited iPS cells for targeting malignant glioma
por: Tamura, Ryota, et al.
Publicado: (2022)

The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy
por: Nakamoto, Fumiko Kusunoki, et al.
Publicado: (2018)

A Case of Painless Legs and Moving Toes Syndrome in Parkinson's Disease Responsive to Dopaminergic Therapy
por: Kawajiri, Sumihiro, et al.
Publicado: (2016)

Escape from Pluripotency via Inhibition of TGF-β/BMP and Activation of Wnt Signaling Accelerates Differentiation and Aging in hPSC Progeny Cells
por: Fujimori, Koki, et al.
Publicado: (2017)

Robust and efficient knock-in in embryonic stem cells and early-stage embryos of the common marmoset using the CRISPR-Cas9 system
por: Yoshimatsu, Sho, et al.
Publicado: (2019)

Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice
por: Sato, Shigeto, et al.
Publicado: (2018)

ET-1 STEM CELL-BASED GENE THERAPY FOR MALIGNANT GLIOMA USING GENOME-EDITED HUMAN INDUCED PLURIPOTENT STEM CELLS
por: Tamura, Ryota, et al.
Publicado: (2022)

Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease Modeling
por: Matsumoto, Takuya, et al.
Publicado: (2016)

Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations
por: Iwasawa, Chizuru, et al.
Publicado: (2019)

A versatile toolbox for knock-in gene targeting based on the Multisite Gateway technology
por: Yoshimatsu, Sho, et al.
Publicado: (2019)

Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD
por: Imaizumi, Kent, et al.
Publicado: (2022)

Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis – Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial)
por: Morimoto, Satoru, et al.
Publicado: (2019)

Dual usage of a stage-specific fluorescent reporter system based on a helper-dependent adenoviral vector to visualize osteogenic differentiation
por: Sone, Takefumi, et al.
Publicado: (2019)

miRNA-Based Rapid Differentiation of Purified Neurons from hPSCs Advancestowards Quick Screening for Neuronal Disease Phenotypes In Vitro
por: Ishikawa, Mitsuru, et al.
Publicado: (2020)

BMP-induced REST regulates the establishment and maintenance of astrocytic identity
por: Kohyama, Jun, et al.
Publicado: (2010)

Current status and prospects of regenerative medicine for spinal cord injury using human induced pluripotent stem cells: a review
por: Inoue, Mitsuhiro, et al.
Publicado: (2023)

Degradation of Extracellular Matrix by Matrix Metalloproteinase 2 Is Essential for the Establishment of the Blood-Brain Barrier in Drosophila
por: Kanda, Hiroshi, et al.
Publicado: (2019)

Reprogramming non-human primate somatic cells into functional neuronal cells by defined factors
por: Zhou, Zhi, et al.
Publicado: (2014)

Single‐cell study of neural stem cells derived from human iPSCs reveals distinct progenitor populations with neurogenic and gliogenic potential
por: Lam, Matti, et al.
Publicado: (2019)

Flexible and Accurate Substrate Processing with Distinct Presenilin/γ-Secretases in Human Cortical Neurons
por: Watanabe, Hirotaka, et al.
Publicado: (2021)

Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer
por: Watanabe, Moe, et al.
Publicado: (2018)

A Cell-Based High-Throughput Screening Identified Two Compounds that Enhance PINK1-Parkin Signaling
por: Shiba-Fukushima, Kahori, et al.
Publicado: (2020)

Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application
por: Hiramatsu, Satoe, et al.
Publicado: (2022)

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia
por: Ueno, Shin-ichi, et al.
Publicado: (2020)

Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice
por: Yamazaki, Kazuto, et al.
Publicado: (2023)

Irf5 siRNA-loaded biodegradable lipid nanoparticles ameliorate concanavalin A-induced liver injury
por: Kawase, Wataru, et al.
Publicado: (2021)

Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
por: Mizuno, Yoshikuni, et al.
Publicado: (2017)

Galectin-1 is expressed in early-type neural progenitor cells and down-regulates neurogenesis in the adult hippocampus
por: Imaizumi, Yoichi, et al.
Publicado: (2011)

Modeling phenotypes of malignant gliomas
por: Sampetrean, Oltea, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1hcvpo8k37cbj3rn0ds4j28v4h